• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾上腺切除术治疗醛固酮瘤后影响高血压完全治愈的因素:大宗病例系列研究结果

Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large series.

作者信息

Zhang Xiaohua, Zhu Zhaowei, Xu Tianyuan, Shen Zhoujun

机构信息

Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, PR China.

出版信息

Urol Int. 2013;90(4):430-4. doi: 10.1159/000347028. Epub 2013 Mar 5.

DOI:10.1159/000347028
PMID:23466491
Abstract

OBJECTIVE

The purpose of this study was to evaluate the impact of hypokalemia on hypertension outcomes in patients with aldosterone-producing adenoma (APA) after adrenalectomy and to determine the factors affecting complete hypertension cure in a large series.

METHODS

Characteristics from 376 APA patients treated with adrenalectomy between 2005 and 2011 were collected from our center. Factors affecting complete hypertension cure were assessed using logistic regression.

RESULTS

At the end of follow-up, 207 (55.05%) patients were completely cured, whereas 138 (36.7%) patients were improved, and 31 (8.3%) patients remain refractory. Age (p = 0.028), >2 antihypertensive agents (p < 0.001), duration of hypertension (p < 0.001), duration of hypokalemia (p = 0.037), systolic blood pressure (p = 0.016), and level of plasma aldosterone (p < 0.001) were associated with hypertension outcomes in univariate analysis. However, multivariate logistic regression analysis showed that only duration of hypertension ≥6 years (OR = 0.496, 95% CI 0.323-0.762, p = 0.001) and level of plasma aldosterone ≥35 ng/dl (OR = 0.503, 95% CI 0.326-0.776, p = 0.002) were the significantly independent factors affecting complete hypertension cure.

CONCLUSIONS

This is the largest series to show that only duration of hypertension and level of plasma aldosterone were the factors affecting complete hypertension cure after adrenalectomy for APA. This study highlights the importance of early diagnosis and early adrenalectomy.

摘要

目的

本研究旨在评估低钾血症对肾上腺切除术后醛固酮瘤(APA)患者高血压转归的影响,并确定影响大量患者高血压完全治愈的因素。

方法

收集2005年至2011年间在本中心接受肾上腺切除术的376例APA患者的特征。采用逻辑回归评估影响高血压完全治愈的因素。

结果

随访结束时,207例(55.05%)患者完全治愈,138例(36.7%)患者病情改善,31例(8.3%)患者仍难治。单因素分析显示,年龄(p = 0.028)、使用>2种抗高血压药物(p < 0.001)、高血压病程(p < 0.001)、低钾血症病程(p = 0.037)、收缩压(p = 0.016)和血浆醛固酮水平(p < 0.001)与高血压转归相关。然而,多因素逻辑回归分析显示,只有高血压病程≥6年(OR = 0.496,95%CI 0.323 - 0.762,p = 0.001)和血浆醛固酮水平≥35 ng/dl(OR = 0.503,95%CI 0.326 - 0.776,p = 0.002)是影响高血压完全治愈的显著独立因素。

结论

这是最大规模的系列研究,表明只有高血压病程和血浆醛固酮水平是APA肾上腺切除术后影响高血压完全治愈的因素。本研究强调了早期诊断和早期肾上腺切除术的重要性。

相似文献

1
Factors affecting complete hypertension cure after adrenalectomy for aldosterone-producing adenoma: outcomes in a large series.肾上腺切除术治疗醛固酮瘤后影响高血压完全治愈的因素:大宗病例系列研究结果
Urol Int. 2013;90(4):430-4. doi: 10.1159/000347028. Epub 2013 Mar 5.
2
Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.尿醛固酮与活性肾素比值:预测醛固酮瘤患者肾上腺切除术后高血压缓解的有用工具。
Am J Hypertens. 2008 Jul;21(7):742-7. doi: 10.1038/ajh.2008.175. Epub 2008 Apr 24.
3
Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients.血管重塑和高血压持续时间可预测原发性醛固酮增多症患者肾上腺切除术的结果。
Hypertension. 2008 May;51(5):1366-71. doi: 10.1161/HYPERTENSIONAHA.108.111369. Epub 2008 Mar 17.
4
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.醛固酮作为原发性醛固酮增多症中心血管代谢综合征的关键介质:一项观察性研究。
J Hypertens. 2007 Jan;25(1):177-86. doi: 10.1097/HJH.0b013e3280108e6f.
5
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.原发性醛固酮增多症患者行肾上腺切除术的血压结局:有无单侧腺瘤的情况
J Hypertens. 2008 Sep;26(9):1816-23. doi: 10.1097/HJH.0b013e3283060f0c.
6
Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism.原发性醛固酮增多症患者肾上腺切除术后的长期血压控制
Surgery. 2014 Dec;156(6):1394-402; discussion1402-3. doi: 10.1016/j.surg.2014.08.021. Epub 2014 Nov 11.
7
Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?对于所有原发性醛固酮增多症患者,在进行肾上腺切除术之前都有必要进行肾上腺静脉采血吗?
J Vasc Interv Radiol. 2008 Jan;19(1):66-71. doi: 10.1016/j.jvir.2007.08.022.
8
Assessment of the Aldosteronona resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients.评估醛固酮消退评分作为法国患者醛固酮瘤肾上腺切除术后高血压预测性消退评分的情况。
Langenbecks Arch Surg. 2017 Mar;402(2):309-314. doi: 10.1007/s00423-017-1557-x. Epub 2017 Jan 22.
9
Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.醛固酮瘤治疗后肾功能与残余高血压的关联
Am J Kidney Dis. 2009 Oct;54(4):665-73. doi: 10.1053/j.ajkd.2009.06.014. Epub 2009 Jul 23.
10
Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.醛固酮腺瘤患者的肾上腺切除术可改善颈动脉内膜中层厚度增加和动脉僵硬度。
Atherosclerosis. 2012 Mar;221(1):154-9. doi: 10.1016/j.atherosclerosis.2011.12.003. Epub 2011 Dec 8.

引用本文的文献

1
A predictive nomogram for incomplete clinical success after unilateral adrenalectomy in patients with primary aldosteronism.原发性醛固酮增多症患者单侧肾上腺切除术后不完全临床成功的预测列线图。
Front Endocrinol (Lausanne). 2025 Jul 24;16:1628564. doi: 10.3389/fendo.2025.1628564. eCollection 2025.
2
Novel predictive factors scoring model for persistent hypertension after adrenalectomy in patients with primary aldosteronism.原发性醛固酮增多症患者肾上腺切除术后持续性高血压的新型预测因素评分模型
Sci Rep. 2025 May 29;15(1):18935. doi: 10.1038/s41598-025-03912-w.
3
Predictive factors of clinical success after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis.
原发性醛固酮增多症肾上腺切除术临床成功的预测因素:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2022 Aug 18;13:925591. doi: 10.3389/fendo.2022.925591. eCollection 2022.
4
Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis.原发性醛固酮增多症患者接受药物与手术治疗的复合心血管结局:一项荟萃分析。
Front Endocrinol (Lausanne). 2021 May 17;12:644260. doi: 10.3389/fendo.2021.644260. eCollection 2021.
5
Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.基础血浆醛固酮浓度可预测原发性醛固酮增多症的治疗效果。
J Endocr Soc. 2020 Feb 13;4(4):bvaa011. doi: 10.1210/jendso/bvaa011. eCollection 2020 Apr 1.
6
Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism.单侧肾上腺切除术治疗原发性醛固酮增多症的临床转归。
JAMA Surg. 2019 Apr 1;154(4):e185842. doi: 10.1001/jamasurg.2018.5842. Epub 2019 Apr 17.
7
Update on the Aldosterone Resolution Score and Lateralization in Patients with Primary Aldosteronism.原发性醛固酮增多症患者醛固酮清除评分及侧别判断的最新进展
Endocrinol Metab (Seoul). 2018 Sep;33(3):352-354. doi: 10.3803/EnM.2018.33.3.352.
8
Factors Associated with Resolution of Hypertension after Adrenalectomy in Patients with Primary Aldosteronism.原发性醛固酮增多症患者肾上腺切除术后高血压缓解的相关因素
Endocrinol Metab (Seoul). 2018 Sep;33(3):355-363. doi: 10.3803/EnM.2018.33.3.355. Epub 2018 Aug 14.
9
Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications.原发性醛固酮增多症患者经 I-131-6β-碘甲基去甲胆固醇单光子发射/计算机断层扫描定位且未停用或调整抗高血压药物情况下的手术结果。
Tzu Chi Med J. 2018 Jul-Sep;30(3):169-175. doi: 10.4103/tcmj.tcmj_106_17.
10
New Advances in the Diagnostic Workup of Primary Aldosteronism.原发性醛固酮增多症诊断检查的新进展
J Endocr Soc. 2017 Jan 27;1(3):149-161. doi: 10.1210/js.2016-1107. eCollection 2017 Mar 1.